Preemption, Tort Reform, And Pharmaceutical Claims: Part Two: Has the Food and Drug Administration Shown It is Solely Responsible for the Protection of Patients? can It Do So? will It Do So?(Medicolegal Issues)

Preemption, Tort Reform, And Pharmaceutical Claims: Part Two: Has the Food and Drug Administration Shown It is Solely Responsible for the Protection of Patients? can It Do So? will It Do So?(Medicolegal Issues)

There should be no question that adverse drug events are a significant issue. A recent report indicated that in 2005 there were 89,842 serious adverse drug-related events (1), and 15,107 of these adverse events were deaths (1). In 2002, adverse drug events were associated with more than 3 million hospital admissions and increased the US […]

Evaluation of a Self-Paced Learning Module to Teach Responsible Literature Searching for Research (Report)

Evaluation of a Self-Paced Learning Module to Teach Responsible Literature Searching for Research (Report)

BACKGROUND The unanticipated death of a healthy research study volunteer at a major university highlighted the importance of a comprehensive and exhaustive literature review in conducting responsible research [1]. When this unfortunate event was investigated, it became evident that many researchers who perform literature searches have little guidance about what constitutes an appropriate or sufficient […]